Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by stockmonster6on Mar 04, 2021 10:17am
78 Views
Post# 32714195

RE:RE:Patient people need.... NOT.... read this !!!

RE:RE:Patient people need.... NOT.... read this !!!There are more than one type of pregnancy test.

Regardless of some other potential rapid tests being out there, there is a need for this regardless.
If N.American market gets saturated, then THRM can sell them to Europe, Asia, Africa etc...  

I'm not too worried.  I think the SP is slacking just because they seem to be behind their original timeline intent; the 'finding' of the test site to do the 100/300 test was delayed when most of us were hoping this was being in progress already.  However, it should not take long to get the needed sample, lock in the final product design after the 100 then onto live testing with 300 pers.

I'm thinking week 3-4 in March will be results; unless they post the locked in product results first prior to the 300 pers study.  When they get to HC approval phase, THRM will rise pretty quickly.
<< Previous
Bullboard Posts
Next >>